Altimmune, Inc.

The table below shows Altimmune, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Altimmune, Inc. reported annual revenue of $41.00K for fiscal year 2025. That is up 105.0% from $20.00K in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $3.24M (FY 2016) to $41.00K. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.